GlobalData

www.globaldata.com

40-42 Hatton Garden
London
EC1N 8EB
United Kingdom

+44 207 406 6789

Activities

R and D

Related Content

Eli Lilly’s acquisition of Loxo Oncology will result in quick return of investment

BMS' acquisition of Celgene could position the company amongst top five most profitable pharma giants

Drug pricing and reimbursement concerns will remain the leading impediment to industry growth in 2019

R&D returns fall to lowest level in 9 years, says Deloitte and GlobalData

Immuno-oncology drug development and personalised medicine will continue to reshape the pharma industry in 2019

Drug development in neuroimmunology to witness strong growth in the 8MM

Big Data and AI to transform healthcare by driving innovation, growing revenues and increasing operational efficiencies

GSK and Pfizer deal shows shift in strategy shift to create the leader in over-the-counter products

Bayer receives European approval for haemophilia drug Jivi ... but has stiff competition ahead

Second failure of AstraZeneca’s Imfinzi + tremelimumab combination significant setback says GlobalData

Similar Companies